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U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES 
CENTERS FOR DISEASE CONTROL AND PREVENTION 
HEALTH RESOURCES AND SERVICES ADMINISTRATION 
CDC/HRSA ADVISORY COMMITTEE ON HIV, 
VIRAL HEPATITIS AND STD PREVENTION AND TREATMENT 
November 13-14, 2013 
Rockville, Maryland 
Minutes of the Virtual Meeting 
The U.S. Department of Health and Human Services (HHS), the Centers for Disease Control 
and Prevention (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention 
(NCHHSTP), and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau 
(HAB) convened the first virtual meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment (CHAC).  The virtual meeting was held on 
November 13-14, 2013. 
CHAC is chartered to advise the Secretary of HHS, Director of CDC, and Administrator of HRSA 
on objectives, strategies, policies and priorities for HIV, viral hepatitis and STD prevention and 
treatment efforts for the nation. 
Opening Session: November 13, 2013
Laura Cheever, MD, ScM 
Associate Administrator and Chief Medical Officer, HIV/AIDS Bureau 
Health Resources and Services Administration 
CHAC Designated Federal Official, HRSA 
Dr. Cheever conducted a roll call to determine the CHAC voting members, ex-officio members 
and liaison representatives who were attending the virtual meeting.  She announced that CHAC 
meetings are open to the public and all comments made during the proceedings are a matter of 
public record. 
Dr. Cheever informed the CHAC voting members of their individual responsibility to identify real 
or perceived conflicts of interest and recuse themselves from voting or participating in these 
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matters.  She asked the CHAC voting members to publicly disclose their individual and/or 
institutional conflicts of interest for the record. 
• Virginia Caine, MD: Recipient of federal funding from CDC (Gonorrhea Network 
Surveillance System) and HRSA (Ryan White) 
• Guillermo Chacon: Recipient of federal funding from CDC and the Substance Abuse and 
Mental Health Services Administration (SAMHSA) 
• Angelique Croasdale, MA:  Recipient of federal funding from CDC and HRSA 
• Carlos del Rio, MD:  Recipient of federal funding from CDC for gonorrhea laboratory 
research; care provider in a HRSA-funded Ryan White clinic 
• Dawn Fukuda, ScM:  Recipient of federal funding from CDC and HRSA (Ryan White 
Part B and Special Projects of National Significance (SPNS)) 
• Steven Johnson, MD:  Recipient of federal funding from the National Institutes of Health 
(NIH) and HRSA (Ryan White); consultant to Gilead and Viva Pharmaceutical 
• Kali Lindsey:  Recipient of federal funding from a CDC Capacity Building Cooperative 
Agreement (CoAg) 
Dr. Cheever announced that the voting members and ex-officio members constituted a quorum 
for CHAC to conduct its business on November 13, 2013.  She called the proceedings to order 
at 10:06 a.m. and welcomed the participants to day 1 of the first virtual CHAC meeting. 
The participants joined Dr. Cheever in congratulating Dr. Jonathan Mermin on his new 
appointment as the NCHHSTP Director and in his new role as the CHAC Designated Federal 
Official (DFO) for CDC.  The participants also welcomed Dr. Elinore McCance-Katz in her role 
as the new ex-officio member for SAMHSA. 
Antigone Dempsey MEd, CHAC co-Chair 
Deputy Director, Knowledge, Transfer and Technical Assistance 
HIV/AIDS Lead, Altarum Institute 
Jeanne Marrazzo, MD, MPH, CHAC co-Chair 
Professor of Medicine, Harborview Medical Center 
University of Washington 
Ms. Dempsey and Dr. Marrazzo also welcomed the participants to the first virtual CHAC 
meeting.  They hoped that the availability of 300 open lines would increase public access and 
participation in CHAC meetings.  They emphasized that the CHAC co-Chairs and DFOs would 
rigorously evaluate the virtual meetings on an ongoing basis to make technical improvements 
and streamline the overall process.  They asked the CHAC members to submit feedback on the 
first virtual meeting to guide the evaluation. 
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Ms. Dempsey concluded the opening session by reviewing the agenda for the November 13-14, 
2013 CHAC meeting.  She pointed out that instructions would be given for the public to make 
comments to CHAC during the public comment session. 
CDC/NCHHSTP Director’s Report
Jonathan Mermin, MD, MPH 
Director, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention 
Centers for Disease Control and Prevention 
CHAC Designated Federal Official, CDC 
Dr. Mermin covered the following topics in his Director’s report to CHAC.  At the agency level, 
the budget is uncertain because CDC is operating under a continuing resolution.  In FY2013, 
CDC operated under a sequester of funds with cuts of 5% to 6% across all NCHHSTP program 
areas.  CDC currently is operating at level funding from FY2013 sequester amounts.  An 
additional sequester is possible in FY2014. 
CDC released the Antibiotic Resistance Threats in the United States-2013 Report in October 
2013.  The report noted that >2 million persons in the United States are infected each year with 
an antibiotic-resistant infection and 23,000 persons die from these infections.  The report 
classified drug-resistant gonorrhea as an “urgent” threat and drug-resistant tuberculosis (TB) as 
a “serious” threat. 
Key findings in the report are highlighted as follows.  The reported TB incidence in 2012 of ~3.2 
persons/100,000 population was the lowest in U.S. recorded history.  Trends in HIV/TB co-
infected persons have decreased to 7.5%.  CDC recently issued guidelines in two Morbidity and 
Mortality Weekly Report articles:  (1) the use of bedaquiline for the treatment of multidrug-
resistant TB and (2) the availability of a new nucleic acid assay that can detect rifampin 
resistance and Mycobacterium tuberculosis without the need for culture.  The report is available 
on the CDC.gov website. 
The CDC Office of Health Equity celebrated its 10th anniversary on November 7, 2013.  The 
keynote presentation, “From Theory to Action: Applying Social Determinants of Health to Public 
Health Practice,” was extremely well received across all parts of CDC.  The presentation 
emphasized the importance of taking actions to increase health equity for all diseases.  CDC will 
release a new Vitalsigns Report and other publications in conjunction with World AIDS Day and 
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At the National Center level, Dr. Mermin’s appointment as the new NCHHSTP Director created 
a vacancy in the position of the Director of the Division of HIV/AIDS Prevention.  Searches are 
underway to fill this position as well as the Director of the Division of Adolescent and School 
Health.  NCHHSTP leadership is serving as Acting Directors in these positions until the 
permanent appointments are made. 
NCHHSTP released its expanded “Atlas” with local, county-level epidemiological data for HIV 
and STDs to enhance capacity to identify areas of the United States with the greatest or least 
disease burden.  NCHHSTP published a supplement to Public Health Reports on “Applying 
Social Determinants of Health to Public Health Practice.” 
At the division level, the Division of HIV/AIDS Prevention (DHAP) released results of a study in 
July 2013 showing that pre-exposure prophylaxis (PrEP) prevents HIV among injection drug 
users.  DHAP conducted the study in partnership with the Thailand Ministry of Public Health and 
Bangkok Metropolitan Administration.  The study reported that a daily dose of PrEP reduced the 
risk of HIV acquisition by 49%.  DHAP issued interim guidance on the use of PrEP for IDUs, but 
the official PrEP guidelines are currently undergoing the HHS clearance process. 
DHAP released its first Rapid Feedback Report (RFR) for grantees of the “Young Men Who 
Have Sex with Men (MSM) and Transgender Persons of Color” Funding Opportunity 
Announcement (FOA).  The purpose of the RFR is to compile 6th month and annual data from 
grantees, highlight major indicators, and provide grantees with a report of their progress 
compared to the FOA goals and the performance of other grantees.  The RFR also reduces the 
overall burden and frequency of data reporting by 25%-30%.  The RFR has an added benefit of 
allowing grantees with less progress to obtain advice, guidance and support from high 
performing grantees. 
DHAP issued a new five-year FOA for capacity building assistance (CBA) for high impact 
prevention.  The funds will support a national CBA Provider Network to serve health 
departments, community-based organizations (CBOs) and healthcare organizations.  The 
application deadline was October 2, 2013 and awards will be made in the spring of 2014.  
DHAP launched “Reasons/Razones” as the first national bilingual campaign to encourage HIV 
testing among Latino gay/bisexual men. 
The Division of Viral Hepatitis (DVH) led CDC’s investigation that identified the source of a 
multi-state outbreak of hepatitis A virus (HAV).  The U.S. Food and Drug Administration and 
multiple state health departments collaborated with CDC on the investigation.  Pomegranate 
seeds from Turkey were identified as the source of the outbreak.  Of 162 persons who were 
confirmed with HAV after eating frozen foods containing Turkish pomegranate seeds, 71 were 
hospitalized.  The affected food companies recalled their products and no new infections have 
been documented since that time. 
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DVH launched the “Know More Hepatitis B” Campaign in June 2013.  The national multimedia 
campaign is targeted to Asians/Pacific Islanders and was released in English, Chinese, 
Vietnamese and Korean.  DVH partnered with Hep B United in this initiative.  The reach of the 
campaign included total television airplay of 1,590 spots with the public service announcement 
and >26 million digital impressions.  DVH released the “2011 Viral Hepatitis Surveillance 
Report” on the CDC.gov website. 
DVH will host a TwitterChat with Hep B United, the Hepatitis B Foundation, and the Association 
of Asian Pacific Community Health Organizations on November 19, 2013 at 3:00 p.m. to discuss 
the “Know Hepatitis B” Campaign. 
The Division of STD Prevention (DSTDP) completed a clinical trial with support from NIH to 
identify new treatment options in the face of growing antibiotic resistance.  The clinical trial 
found that two new antibiotic regimens successfully treated gonorrhea infections:  injectable 
gemtamicin in combination with oral azithromicin and oral gemifloxacin with oral azithromicin.  
DSTDP will host the 2014 STD Prevention Conference in June 2014 in Atlanta.  The deadline 
for submitting abstracts for the conference is November 15, 2013. 
DSTDP published a study in June 2013 that reported a 56% decrease in vaccine-type human 
papillomavirus (HPV) among female teens 14-19 years of age since the introduction of HPV 
vaccine in 2006.  DSTDP and its partners released an application for the new STD Treatment 
Guidelines that will be issued in the near future.  The application provides clinicians and other 
healthcare providers with a quick reference on the identification and treatment of STDs.  The 
application is available for Apple and Android electronic devices at no charge and can be 
downloaded from iTunes, Google Play or at http://apps.usa.gov/std-treatment-guide.shtml. 
The Division of Adolescent and School Health (DASH) awarded funds for a new five-year school 
health FOA, “Promoting Adolescent Health Through School-Based HIV/STD Prevention and 
School-Based Surveillance.”  Funds were awarded to states with the highest HIV burden and 
also to local school districts based on their HIV/STD burden, poverty level and number of 
students.  The FOA also includes prevention funds for young MSM.  School districts were 
encouraged to provide a safe and supportive environment for lesbian/gay/bisexual/transgender 
(LGBT) youth. 
DASH released the updated “Health Education Curriculum Analysis Tool” to help school districts 
and schools analyze and ensure that their health education curricula follow federal guidelines.  
DASH released results of the “2012 School Health Policies and Practices Study.”  The national 
survey assesses school health policies and practices.  Key results of the study are highlighted 
below: 
• A decrease in the percentage of school districts that require elementary schools to teach 
HIV prevention (from 59% in 2000 to 40% in 2012) 
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• A decrease in the percentage of school districts that require elementary schools to teach 
STD prevention (from 39% in 2000 to 29% in 2012) 
• An increase in the percentage of school districts with policies that allow parents to 
exclude children from high school HIV or STD prevention education (from 62% in 2000 
to 78% in 2012) 
DASH will host a TwitterChat with its education and public health partners on November 21, 
2013 at 2:00 p.m.  The TwitterChat will focus on strengthening HIV/STD prevention strategies 
for youth. 
HRSA/HAB Associate Administrator’s Report 
Laura Cheever, MD, ScM 
Associate Administrator and Chief Medical Officer, HIV/AIDS Bureau 
Health Resources and Services Administration 
CHAC Designated Federal Official, HRSA 
Dr. Cheever covered the following topics in her Associate Administrator’s report to CHAC.  
HRSA is pleased that the Obama Administration strongly supports the Ryan White HIV/AIDS 
Program (RWHAP) and continuation of its services.  Even with full implementation of the 
Affordable Care Act (ACA), the Administration has stated that RWHAP will continue to play a 
critical role in improving health outcomes along the continuum of care (i.e., the “Treatment 
Cascade”). 
HAB created a visual framework to illustrate RWHAP’s multiple functions.  In addition to its core 
function of service delivery, RWHAP also plays an important role in four other components of 
the health sector:  policy, assessment, capacity development and quality.  HAB provides strict 
oversight to assure that all five of the RWHAP functions support the National HIV/AIDS Strategy 
(NHAS) goal of “0 new infections.” 
For service delivery, HAB provides a seamless system of care for persons living with HIV 
(PLWH) due to the statutory role of RWHAP as the payer of last resort.  HAB funds essential 
health services and treatment in order for PLWH to remain in care and achieve viral 
suppression.  HAB takes a public health approach to provide a comprehensive system of care 
for low-income PLWH based on four key objectives:  reduce new infections, improve health 
outcomes, increase the quality of life of PLWH, and decrease health-related disparities. 
HAB ensures that RWHAP’s basic and important principles are met, particularly the inclusion 
and engagement of PLWH in the planning of services and the responsibility of providers to 
ensure that patients are retained in care.  HAB awards funding for its grantees and stakeholders 
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to implement public health interventions that prevent and reduce transmission of HIV and 
achieve positive health outcomes. 
For policy, HAB plays an integral role by providing guidance to other HRSA bureaus on federal, 
state and local policy initiatives that impact PLWH.  HAB funds RWHAP positions in state and 
local governments to ensure that important input is provided on HIV at state and local levels.  
HAB engages federal, state, local and community stakeholders to assist in achieving the NHAS 
goal of 0 new infections.  HAB establishes federal HIV care and treatment policy guidelines that 
are effective for PLWH and are relevant for the national goal of achieving an AIDS-free 
generation. 
For assessment, HAB ensures that its grantees adhere to the Congressionally-mandated 
statute to identify and fill gaps in RWHAP.  HAB collaborates with its state and local partners to 
examine models of care and service delivery to ensure that RWHAP is maintained as a high-
quality and cost-effective program. 
HAB collaborates with health professionals to determine the capacity and training needs of an 
interdisciplinary healthcare workforce and also to provide a comprehensive system of care for 
PLWH.  Most notably, HAB-funded AIDS Education and Training Centers (AETCs), states and 
cities specifically identify service gaps in their individual regions, states and local jurisdictions.  
HAB analyzes and monitors the public health impact of the HIV healthcare system that is 
supported by RWHAP funds. 
For capacity development, HAB ensures that HIV care and treatment services funded by 
RWHAP are aligned with and follow the epidemic.  Over the past few years, for example, HAB 
has targeted more RWHAP resources to build capacity in the South and specific cities because 
the HIV epidemic has increased in these areas. 
HAB’s technical assistance (TA) and support have allowed RWHAP service providers to create 
evidence-based models of care, develop interdisciplinary workforce teams and build patient-
centered medical homes (PCMHs).  HAB-funded SPNS Initiatives help to integrate health 
information systems to track health outcomes, monitor investments, and identify gaps in the 
continuum of care at the jurisdictional level. 
For quality, HAB ensures that RWHAP grantees adhere to the Congressionally-mandated 
statute related to quality management.  HAB empowers stakeholders to deliver high-quality HIV 
care and treatment.  HAB played a critical role in establishing and monitoring HIV performance 
measures and assuring consistency and coordination of these indicators across the federal 
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In addition to overseeing RWHAP’s five primary functions, HAB is continuing to monitor the 
RWHAP client population in preparation for full implementation of ACA.  Based on the 2011 
client-level data system, RWHAP served 553,999 clients in 2011.  Of general RWHAP clients 
who received services outside of the AIDS Drug Assistance Program (ADAP), 28% (or 
~128,000) were uninsured.  The 2012 ADAP data are incomplete and only include 29 states at 
this time, but preliminary data indicate that 65% of RWHAP clients are uninsured in ADAP. 
Based on client-level data for non-ADAP clients, ~69% are at a Federal Poverty Level (FPL) of 
<100% and 21% are at an FPL of 101%-200%.  Preliminary data show that most RWHAP 
clients who receive non-ADAP services currently have a form of insurance coverage through 
Medicaid or other sources.  HAB is making strong efforts to fill gaps in coverage for the 
remaining RWHAP clients to ensure continuity and retention in care and adherence to 
medications.  However, most uninsured RWHAP clients will qualify for Medicaid in states that 
will expand Medicaid coverage under ACA. 
States conducted analyses that showed as of October 22, 2013, 25 states elected not to expand 
Medicaid coverage.  The 25 non-Medicaid expansion states were found to serve ~58% of all 
uninsured RWHAP clients who do not receive ADAP services.  In these 25 states, 70.4% of 
uninsured RWHAP clients had incomes at or below 100% of the FPL.  Because many of these 
clients most likely will remain uninsured under ACA, RWHAP funds might be used for premium 
assistance and cost sharing for these clients to enroll in Health Insurance Marketplaces as long 
as coverage is cost-effective and adheres to RWHAP policy.  HAB distributed a policy 
clarification notice to provide states with detailed information in this area. 
The state analyses estimated that ~7.5% of RWHAP clients in the 25 non-Medicaid expansion 
states have incomes between 100%-133% of the FPL.  These clients will be eligible to purchase 
insurance coverage through Health Insurance Marketplaces and also might be eligible for 
premium tax credits and cost-sharing reductions.  Of RWHAP clients who did not receive ADAP 
services prior to ACA, 27% had Medicaid, 9% had Medicare, 28% were uninsured, and 13% 
had insurance from other sources. 
Healthcare coverage options for RWHAP clients will vary after ACA is fully implemented, 
including Medicaid/Medicare, other public insurance, expanded Medicaid coverage in some 
states, and newly opened Health Insurance Marketplaces.  However, both insured and 
uninsured clients will continue to need other RWHAP services that will not be covered by 
Medicaid/Medicare or Health Insurance Marketplaces. 
The RWHAP statute does not allow funds to be used for any item or service to the extent that 
payment has been made or reasonably could expect to be made by another payment source.  
The RWHAP statute requires grantees and contractors to vigorously pursue enrollment of their 
clients in other relevant funding sources or forms of insurance.  RWHAP grantees and 
contractors also are required to make every reasonable effort to ensure that individuals who are 
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not eligible for public programs and are not exempt from ACA requirements to enroll in health 
coverage are assessed for eligibility in private Health Insurance Marketplaces.  RWHAP will 
continue to pay for items and services for individuals who remain uninsured or underinsured. 
Over the past year, HAB has conducted numerous activities in four major domains (e.g., 
communication, policy development, training and TA) to assist RWHAP grantees in preparing 
for ACA implementation.  HAB provided grantees with administrative flexibility and guidance to 
ensure that RWHAP clients make a seamless transition to ACA-funded programs. 
HAB funded a new FOA in FY2013 to JSI Research and Training Institute to focus on ACA 
outreach and enrollment of minorities living with HIV/AIDS.  The objectives of this funding is 
three-fold:  (1) provide RWHAP grantees with TA tools to build capacity in ACA outreach and 
enrollment; (2) collaborate with CDC, SAMHSA, the Centers for Medicare and Medicaid 
Services (CMS) and other HHS agencies to review best practices in ACA outreach and 
enrollment across the federal government; and (3) collaborate with other federal partners to 
develop ACA outreach and enrollment strategies, tools and training for grantees. 
HAB has prioritized several new and ongoing initiatives in FY2014.  HAB will closely collaborate 
with CMS to track outcomes and provide grantees with TA related to the RWHAP-ACA 
Integration Initiative.  HAB will conduct several activities to improve health outcomes along the 
HIV continuum of care, such as launching new SPNS Initiatives and awarding one-time funding 
to RWHAP Parts C and D grantees.  The continuum of care activities will be aligned with the 
NHAS goals and a new White House Executive Order. 
HAB will strengthen both internal and external customer service to staff, grantees and federal 
partners.  HAB will improve grantee oversight through its monthly monitoring calls.  HAB will 
enhance the use of RWHAP data to ensure that data are more efficiently and effectively 
processed, more usable information is disseminated to grantees, and data are maximized to 
improve programmatic outcomes. 
HAB will continue to fund a special study to better understand and more clearly delineate 
services that are not covered by primary insurers, but are available to insured clients who 
present to Ryan White clinics (e.g., case management, medical care and transportation).  HAB 
will revise and update its HIV performance measures portfolio to more strongly emphasize 
health outcomes, ensure that these indicators are aligned with those of other federal partners, 
and shift to a smaller set of measures. 
HAB’s transition to a more efficient and streamlined portfolio is consistent with the National 
Quality Strategy.  Low-priority measures will be deleted and replaced with nationally endorsed 
measures.  Several categories will be combined to develop unified measures.  The 42 
performance measures include core measures and clinical measures for all age groups, 
including adults and adolescents.  Although some performance measures related to case 
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management, ADAP, oral health and systems will be archived in the streamlined portfolio, all 7 
measures endorsed by the HHS Secretary will be included.  HAB and CMS currently are 
coordinating efforts to include four nationally endorsed measures into CMS Meaningful Use 
Stage 3 criteria. 
Several changes have occurred in HAB’s leadership since the June 2013 CHAC meeting.  Dr. 
Cheever was appointed as the Associate Administrator of HAB.  Dr. Sylvia Trent-Adams was 
appointed as the Acting Deputy Associate Administrator of HAB.  Dr. Cheever displayed the 
HAB organizational chart and asked the participants to join her in welcoming the newly 
appointed Branch Chiefs. 
At the agency level, HRSA is continuing to closely collaborate with CDC, other federal partners 
and key stakeholders.  However, efforts are underway to increase coordination and improve 
relationships across other federal programs.  These partnerships will play an important role in 
HRSA’s new activities in FY2014 to reduce the reporting burden on grantees that receive 
funding from multiple federal agencies.  HRSA is collaborating with federal partners to advance 
evidence-based interventions to improve health outcomes along the continuum of care.  HRSA 
is sharing resources and expertise with federal partners to build capacity at the grantee level. 
CHAC discussed the following topics in the question/answer session with Drs. Mermin and 
Cheever on the CDC/NCHHSTP and HRSA/HAB updates. 
• Potential reasons or major drivers for the disappointing decreases in the percentage of 
school districts that require elementary schools to teach HIV and STD prevention. 
• The possibility of CDC conducting a state-by-state study to identify essential public 
health services related to HIV, viral hepatitis and STD prevention that would not be 
covered under ACA. 
• The possibility of an unintended consequence of ACA in which more RWHAP funds 
would be awarded to non-Medicaid expansion states and Medicaid expansion states 
would be “penalized” with less RWHAP funds. 
• CDC’s plans to link its upcoming Prevention with Positives (PwP) Guidelines to 
performance measures in order to expand prevention activities for PLWH and support 
HRSA’s HIV care and treatment efforts. 
• Feedback, acceptability and implementation in the field of CDC’s new algorithm for 
diagnostic laboratory testing of HIV infection. 
The discussion resulted in CHAC advising CDC to collaborate with HRSA and SAMHSA to 
create a SmartPhone application for the PwP Guidelines that would be similar to the new 
application for the STD Treatment Guidelines.  Ideally, the application should be designed to 
calculate alcohol risk scores and depression scores in order for clinicians to emphasize 
prevention in a holistic and comprehensive manner. 
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For example, SAMHSA could replicate its existing SmartPhone applications with quick screens 
for clinicians to address mental disorders, anxiety, depression, alcohol use, and prescription/ 
illicit drug abuse of their HIV patients and make referrals to treatment.  Clinicians also should be 
able to use the new application in conjunction with electronic health records (EHRs). 
Update by the Presidential Advisory Council on HIV/AIDS (PACHA) 
Douglas Brooks, MSW 
Senior Vice President for Health Services 
Justice Resource Institute 
CHAC Liaison Representative, PACHA 
Mr. Brooks covered the following topics in his update to CHAC on PACHA’s recent activities.  
PACHA structured its September 2013 meeting as an open forum with two expert panels.  
Panel 1 was charged with exploring the relationship between ACA and RWHAP.  The panel 
highlighted the major ACA provisions that will benefit PLWH, particularly access to insurance 
regardless of preexisting conditions.  In non-Medicaid expansion states, some PLWH with 
incomes above the FPL will be eligible for subsidies to purchase insurance.  However, other 
PLWH will continue to rely on RWHAP for coverage. 
The panel described multiple services RWHAP provides to PLWH that will not be covered under 
ACA (e.g., medical and nutrition counseling, home meal delivery, home-based care, visual/ 
dental care and housing support).  The panel agreed that coverage completion is the hallmark 
of RWHAP and demonstrably improves health outcomes along the continuum of care for PLWH. 
The panel noted that although many Southern states have elected not to expand Medicaid 
coverage, access to HIV care is particularly problematic in these jurisdictions.  Low-income 
PLWH in these states who would not be eligible for subsidies as well as undocumented 
immigrants who would not be eligible for ACA coverage will be the most severely impacted 
populations.  ACA will offer tremendous opportunities to reduce the number of uninsured 
persons in the United States, but existing challenges for PLWH still need to be addressed. 
The panel discussed the successful Massachusetts model in which 95% of the population has 
health insurance coverage, while RWHAP funds are used to ensure coverage completion and 
offset some costs of purchasing insurance.  The panel highlighted the most impressive 
outcomes of the Massachusetts model:  a 45% decrease in new HIV/AIDS diagnoses, a 20% 
reduction in AIDS-related deaths, and improved health outcomes across diverse populations.  
Most notably, two studies reported that >70% of PLWH in Massachusetts have achieved viral 
suppression higher than the national goal. 
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The panel hoped that the seven-year timeline for Massachusetts to expand the sole RWHAP 
system of care to a broader system of universal access to care would be shorter for other 
states.  However, the panel was aware of the specific amount of time that would be required for 
certain states and local jurisdictions to modify their existing infrastructures to meaningfully serve 
PLWH in a responsive manner.  The panel described changes that would need to be made in 
several areas to achieve this goal:  engagement and retention in care, medical services, 
laboratory treatment, and public health interventions.  
Panel 2 was charged with considering the implications if RWHAP is not reauthorized in the 
future; proposing strategies to reach PLWH in localities with limited services; exploring 
approaches to manage co-morbidities; and making recommendations to successfully reach the 
prevention and treatment goals.  The panel was pleased that the Obama Administration 
recognized the need to continue RWHAP in order to improve health outcomes for PLWH and 
proposed a $20 million increase with discretionary dollars in the FY2014 President’s budget. 
The panel pointed out that 70% of RWHAP beneficiaries currently have a form of insurance 
coverage, but some clients will still need RWHAP services after ACA is fully implemented.  The 
panel emphasized the need to efficiently use resources to better meet the needs of 
marginalized populations and maximize workforce capacity to improve care for PLWH.  
However, the panel raised questions regarding specific legislation to enact or existing policies to 
modify to effectively and equitably allocate resources. 
The panel extensively discussed RWHAP’s statutory role as the payer of last resort.  Even after 
full ACA implementation, RWHAP will still be needed to engage and retain insured PLWH in 
care, reach and meet the needs of uninsured PLWH, and provide crucial non-medical services 
(e.g., intensive case management and housing assistance). 
The panel described several of HRSA’s actions that are particularly relevant for ACA.  HRSA 
issues waivers to some grantees regarding their requirement to allocate RWHAP funds for core 
services.  HRSA has encouraged grantees to align their screening and eligibility determinations 
with Health Insurance Marketplaces in order to take advantage of the open enrollment period.  
HRSA has informed grantees of their responsibility to ensure that RWHAP funds for services 
are more cost effective than private insurance. 
The panel characterized RWHAP as a hallmark of a public/private partnership and was in favor 
of using the delay in RWHAP reauthorization as an opportunity to consider the future needs and 
structure of the program.  Most notably, specific components of the current healthcare system 
and barriers to PLWH fully utilizing these services should be better understood as more persons 
will be encouraged to seek care under ACA. 
The panel agreed on the importance of reframing HIV as a chronic disease and a public health 
imperative to reduce stigma and prevent the spread of disease, but individual panelists were 
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divided on the structure of RWHAP in the future.  Some panelists noted that RWHAP serves as 
a “life line” to PLWH and should not be disrupted until a better replacement has been identified.  
Some panelists believed that RWHAP, in its current structure, should not be perpetuated or 
reauthorized.  Some panelists were in favor of expanding RWHAP to a broader “Coverage 
Completion Program” for persons with a range of chronic diseases.  
The panel was aware that some providers currently are delaying the treatment of HIV/hepatitis 
co-infection because a new regimen is anticipated.  HRSA will develop a specific treatment 
protocol after the new regimen is more widely available.  The panel also noted that despite a 
growing body of evidence, many hepatologists still view RWHAP beneficiaries as poor 
candidates for hepatitis treatment.  The panel agreed that any program with a separate “HIV 
silo” would not be effective for providers or patients because multiple chronic conditions and 
other needs related to increased age would be overlooked. 
The panel discussed the limited success of RWHAP grantees and Community Health Centers 
(CHCs) collaborating to develop a multidisciplinary medical home model for patients.  The panel 
raised the possibility of CHAC placing this topic on a future agenda to propose strategies in this 
area. 
The panel discussed the potential for flexibility in HRSA’s HIV Continuum of Care Initiative to 
address the NHAS goals and improve health outcomes along the continuum of care even if 
RWHAP reauthorization continues to be delayed.  The initiative is designed to provide guidance 
on applying the best evidence-based interventions and using data to inform local community 
efforts.  HRSA has encouraged grantees to implement continuum of care interventions with a 
demonstrated track record of success in the field and collect additional data on health impacts.  
These data should be widely disseminated to assist Planning Councils, CBOs and providers in 
improving care. 
PACHA engaged the panels in extensive discussions on several topics.  HRSA described its 
focus on integrating routine HIV testing and linkage to care in CHCs that currently provide care 
to PLWH, but are not recipients of RWHAP funding.  HRSA informed PACHA of supplemental 
funding that is available for areas of severe need to address disparities, but only a small portion 
of these resources could be targeted to localities with the greatest need. 
CHAC proposed several areas of collaboration with PACHA for the two advisory committees to 
provide additional expertise and guidance to HRSA and HHS on the future of RWHAP. 
• CHAC and PACHA should frame effective messaging to educate Congressional staffers 
on RWHAP’s critical role in advancing public health and improving the individual health 
of PLWH over time.  Congressional staffers should be informed that with the evolution of 
RWHAP under ACA, legislative decisions will need to be made on prioritizing specific 
interventions, ensuring the efficient use of resources, strengthening efforts to meet the 
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needs of marginalized populations, and maximizing workforce capacity to care for 
PLWH.  RWHAP’s tremendous infrastructure of a highly skilled workforce of HIV 
providers should be widely publicized. 
• CHAC and PACHA should compile lessons learned and experiences from the 
Massachusetts model to provide federal agencies with clear guidance on implementing 
universal access to care at the national level.  For example, Massachusetts successfully 
achieved the goal of universal health care across the state, but minimal attention has 
been given to paying for these services under ACA. 
• CHAC and PACHA should explore strategies to resolve problems with the panel’s 
recommendation to expand RWHAP to a broader Coverage Completion Program.  The 
“coverage completion” concept greatly underestimates the extent to which medical care 
is provided to patients during their normal visits to Ryan White clinics.  Outside of ACA, 
patients typically receive care in three areas during their routine clinic visits:  (1) primary 
care to address personal health issues; (2) specialty care to assist in managing 
antiretroviral (ARV) therapy and other HIV complications; and (3) public health care to 
promote prevention and ensure treatment adherence to reduce the spread of HIV and 
other risks.  Clinicians will need clear guidance to continue to comply with RWHAP’s 
statutory role as the payer of last resort, while still providing all three types of care 
without increasing the burden on patients with additional clinic visits.  Messaging also 
should be formulated to highlight RWHAP as an excellent program even with full ACA 
implementation. 
• CHAC and PACHA should issue a position statement to emphasize the link between 
care provided by RWHAP and the persistent incidence of >50,000 new HIV infections 
per year.  To shift from crisis management and make further progress on achieving the 
goal of an AIDS-free generation, RWHAP must be structured as a PwP framework, a 
health disparities framework and a comprehensive system of care for PLWH. 
Panel Presentation: Federal Updates on Affordable Care Act Implementation 
A panel of federal agency representatives presented a series of updates describing the ongoing 
activities of their respective agencies to prepare for implementation of ACA.  The updates are 
summarized below. 
Rebecca Slifkin, PhD 
Director, Office of Planning, Analysis and Evaluation 
Health Resources and Services Administration 
Dr. Slifkin presented an update on HRSA’s ongoing ACA implementation activities.  HRSA is 
continuing to gather ACA outreach and enrollment data from grantees in the field and distribute 
this information to appropriate HHS entities.  HRSA maintains a robust feedback loop with 
 
 
Meeting Minutes: CDC/HRSA Advisory Committee on 
HIV, Viral Hepatitis and STD Prevention and Treatment 
November 13-14, 2013  ♦  Page 15 
 
various HHS entities that are responsible for specific components of ACA implementation.  
HRSA is making strong efforts to address and resolve as many issues in real time as possible. 
HRSA prioritizes each ACA issue during biweekly calls with CMS.  The most common ACA 
questions grantees have raised include designation as a Certified Application Counselor 
Organization (CACO), training for individuals, Medicaid issues, and state barriers to consumer 
assistance and enrollment in ACA. 
Several websites and e-mail addresses have been created for grantees to pose questions and 
receive timely information on ACA.  Organizations can submit questions on CACO designation 
to cacquestions@cms.hhs.gov.  Experiences and success stories related to CACO designation 
can be shared at getcovered@hrsa.gov. 
The “In the Loop” online learning community is open to any organization or individual to share 
experiences and lessons learned related to ACA enrollment (www.enrollmentloop.org).  The 
website includes a mechanism that forwards feedback and questions to the White House and 
HHS agencies.  This mechanism is used to generate reports that broadly address general 
issues and problems, but recommendations also are formulated for HHS to address specific 
concerns. 
Kristen Mangold 
Policy Development Branch Chief, HIV/AIDS Bureau 
Health Resources and Services Administration 
Ms. Mangold presented an update on HAB’s ongoing ACA implementation activities in the 
context of RWHAP.  HAB is continuing to strengthen communications with RWHAP grantees on 
ACA through policy development, training and TA tools.  In terms of communication, HAB 
created a new electronic mailbox for grantees to submit their ACA-related questions; launched 
an ACA-specific webpage that is regularly updated with guidance documents, policy documents 
and other useful tools; and routinely addresses ACA-related issues during its quarterly meetings 
with national partners.  Aggregated responses to ACA-related questions are available to all 
grantees on the webpage, while individual questions are addressed by the grantee’s Project 
Officer.  
In terms of policy development, HAB partnered with CMS to issue an ACA outreach and 
enrollment letter to grantees and a notice of ACA’s key provisions to providers.  The primary 
purpose of these notices was to explain various policy components that will provide grantees 
with as much flexibility as possible while continuing to adhere to RWHAP’s statutory role as the 
payer of last resort.  The policy clarification notices have played an integral role in aligning 
RWHAP and ACA requirements and ensuring that grantees understand the available coverage 
options for PLWH. 
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In terms of training, HAB is continuing to provide training and education to staff and grantees.  
Most notably, HAB and CMS jointly hosted webcasts in conjunction with the release of each 
policy notification.  The webcasts have been well attended with 300-600 participants on 
average.  The next webcast will focus on RWHAP and modified adjusted gross incomes.  
Grantees can access HAB’s ACA-specific webpage to view and download each archived 
webcast, specific updates and frequently asked questions. 
In terms of TA tools, HAB serves on the HRSA-wide ACA Outreach and Education Workgroup.  
HAB has posted answers to ACA frequently asked questions on its website.  HRSA-funded 
Technical Assistance Resource Centers also are helping HAB grantees with ACA outreach and 
enrollment activities.  HAB is aware that grantees in some states have been challenged in 
locating information on specific ACA-related issues (e.g., formularies and the overlap between 
RWHAP core medical services and potential health benefits).  HAB is making strong efforts to 
address these complex questions. 
Stuart Berman, MD, ScM 
Senior Advisor, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention 
Centers for Disease Control and Prevention 
Dr. Berman presented an update on CDC’s ongoing ACA implementation activities.  ACA 
outlines additional requirements for charitable hospitals to maintain their tax-exempt status.  At 
this time, 3,000 U.S. hospitals account for ~$13 billion in tax exemptions.  Hospitals previously 
were granted tax exemptions for conducting charitable community activities only, but the new 
ACA mandate will require hospitals to also conduct Community Health Needs Assessments 
(CHNAs) and adopt an implementation strategy to meet community health needs identified by 
CHNAs. 
Hospitals will be required to obtain input from persons who represent the broad interests of the 
community, including those with special knowledge of or expertise in public health, and make 
the CHNA findings widely available to the public.  CDC advised the Internal Revenue Service 
(IRS) on specific requirements for hospitals to collaborate with health departments in order to 
comply with the ACA mandate. 
In response to CDC’s guidance, the IRS issued a Notice of Proposed Rulemaking on April 5, 
2013.  The language states that a hospital must take into account input from at least one state, 
local, tribal or regional governmental public health department (or an equivalent department or 
agency) with knowledge, information or expertise relevant to the health needs of the community. 
CDC partnered with external stakeholders to develop CHNA web resources and training for 
health departments and also supported the development of “Principles to Consider for the 
Implementation of a Community Health Needs Assessment Process.”  The key CHNA principles 
are highlighted below. 
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• Maximum transparency to improve community engagement 
• Multi-sector collaboration that supports shared ownership of the approach 
• Proactive, broad and diverse community engagement 
• A broad definition of “community” that also addresses disparities 
• Use of high-quality data compiled from diverse sources 
• Use of evidence-based interventions and innovative practices 
CDC reviewed various models and tools that have been applied to conduct a CHNA.  HIV/AIDS, 
STDs and TB were among the most frequently recommended health outcome metrics to 
improve population health in terms of morbidity.  In 2014, CDC’s “Community Health Status 
Indicators” website is expected to have county-level data available for the most commonly cited 
indicators. 
The Center for Medicare and Medicaid Innovation (CMMI) announced round 2 of its Health Care 
Innovation Awards in May 2013.  The $1 billion initiative will fund testing of new payment and 
service delivery models.  CMMI will award funding to ~100 projects, but proposals were 
specifically solicited for four major activities:  (1) rapidly reduce Medicare, Medicaid and/or 
Children’s Health Insurance Program (CHIP) costs in outpatient and/or post-acute settings; (2) 
improve care for populations with specialized needs; (3) transform financial and clinical models 
of specific types of providers and suppliers; and (4) improve the health of populations through 
better prevention efforts. 
For innovation projects in categories 2 and 4, CMMI prioritized HIV/AIDS as a high value target 
of change and emphasized the need for organizations to submit proposals in this area.  CMMI 
defined the “health of populations” by geographic location (the health of a community), clinical 
status (the health of persons with specific diseases), and socioeconomic class.  CMMI further 
noted that population health activities should focus on engagement of beneficiaries, prevention, 
wellness, and comprehensive care extending beyond the clinical service delivery setting.  CDC 
will closely collaborate with CMMI to review and evaluate the HIV/AIDS innovation proposals. 
An important decision was documented in a final Medicaid ruling, published July 15, 2013.  
State Medicaid programs can now reimburse for preventive services when recommended by a 
physician or other licensed practitioner.  Under the new rule, state Medicaid programs 
potentially could reimburse for HIV and STD testing, counseling and other services provided by 
community health workers, other non-clinicians that are state-qualified providers.  CDC will 
compile and provide CMS with models, case studies and best practice approaches to facilitate 
implementation of the new rule. 
In June 2013, the U.S. Preventive Services Task Force (USPSTF) recommended hepatitis C 
virus (HCV) screening of persons at high risk for infection and one-time HCV screening of the 
1945-1965 birth cohort (Grade B).  In September 2013, CMS initiated a national coverage 
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analysis for HCV screening of adults that will be completed on June 3, 2014.  CMS closed the 
public comment period on October 5, 2013 and expects to release its final decision 
memorandum on March 5, 2014.  If CMS approves coverage, HCV screening would be 
available to Medicare recipients without cost sharing. 
Melissa Harris 
Director, Division of Benefits and Coverage 
Disabled and Elderly Health Programs Group 
Centers for Medicare and Medicaid Services 
Ms. Harris presented an update on CMS’s ongoing ACA implementation activities.  CMS is 
continuing to conduct TA activities and provide guidance to both Medicaid expansion states and 
non-Medicaid expansion states regarding coverage of populations via an Alternative Benefit 
Plan.  CMS’s in-depth TA on changes to Medicaid as a result of ACA includes participation in 
daily conference calls with 6-7 states and weekly meetings with other states.  To date, 32 states 
have informed CMS of their intention to use authority under Section 1937 of the Social Security 
Act to provide services to existing and new Medicaid beneficiaries. 
CMS’s TA activities are designed to ensure that states understand the benefit requirements 
outlined in the ACA Essential Health Benefits (EHBs) and Section 1937 of the Social Security 
Act.  The Alternative Benefit Plan (formerly the Medicaid Benchmark Program) provides an 
opportunity for states to craft and offer benefit packages to the new adult populations and other 
Medicaid-eligible persons.  These benefit packages can be similar to or different from services 
states traditionally provide under their plans.  However, ACA has added a floor of coverage to 
Section 1937 that will serve as 10 EHBs in commercial plans selected by states. 
Commercial plans for states to define EHBs for Medicaid will be the same as those used in 
Health Insurance Marketplaces to define EHBs.  The commercial plans include federal and state 
employee plans, the largest commercial non-Medicaid health maintenance organizations, and 
the three largest small-group plans.  The commercial plans represent a variety of options for 
states to select and define EHBs and also to achieve the goals of their respective benefit 
packages. 
CMS is continuing to collaborate with states to ensure that their state plan amendments for their 
new adult populations include all benefits required by ACA and in keeping with state goals for 
service provision.  States must demonstrate to CMS that benefits provided in their plans meet or 
exceed the floor of coverage mandated by ACA. 
CMS is pleased that some EHBs have led to unexpected positive outcomes, particularly the 
inclusion of more robust mental health, substance use and preventive services.  Prior to ACA, 
for example, some state Medicaid plans offered relatively weak substance use benefit packages 
or provided no benefits at all in this area.  Because substance use is listed as an EHB under 
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ACA, all Medicaid expansion states and all states using Section 1937 to authorize benefits for 
traditional Medicaid-eligible groups must include substance use services in their Section 1937 
programs.  A few states have informed CMS of their intention to include substance use services 
in their traditional plans for the remainder of Medicaid-eligible beneficiaries. 
Regardless of services covered in commercial plans, states must meet the federal definition of 
“preventive services” included in the EHB category: all services with a USPSTF Grade A or B 
recommendation, all vaccines recommended by the Advisory Committee on Immunization 
Practices, all of HRSA’s Bright Future preventive services recommendations, and all Institute of 
Medicine (IOM) women’s preventive services recommendations.  This requirement has led 
several states to add the same menu of preventive services to their existing plans by aligning 
benefits between their new adult populations and the remainder of their Medicaid-eligible 
beneficiaries. 
To date, CMS has not approved any proposed actions on state plans to establish benefit 
packages under the Alternative Benefit Plan for the new Medicaid-expanded population.  After 
the approval process is complete, however, CMS will post the state plans on the Medicaid.gov 
website.  The public will be able to review the following information: 
• specific plans selected by states to define EHBs for Medicaid; 
• specific services provided by states as defined in their selected plans; 
• specific services states have added to their Alternative Benefit Plans to exceed the floor 
of EHB coverage; 
• the amount, duration or limitations in scope of services provided in Alternative Benefit 
Plans; and 
• other services outside of commercial plans that states have added in an Alternative 
Benefit Plan (e.g., targeted case management, personal care, long-term nursing facility 
care and freestanding birthing center services). 
CHAC discussed the following topics in the question/answer session with the federal agency 
representatives on the ongoing ACA implementation activities of their respective agencies. 
• The possibility of HRSA compiling information from the “In the Loop” website into simple 
fact sheets or key bullet points for dissemination to grantees, CBOs and other groups. 
• The ability of HRSA to provide state ADAPs with insurance premium rates directly from 
insurers that will offer plans on state Exchanges to ensure PLWH are informed of plans 
with the best value. 
• HRSA’s plans to address the potential for decreased availability of ARVs and diminished 
care for PLWH due to the placement of these drugs in the Tier 4 (highest cost share) 
formulary by private insurance plans. 
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• HRSA’s plans to evaluate successes, challenges and limitations in the overall HIV care 
armamentarium based on collaboration between Ryan White clinics and Medicaid health 
homes that currently serve HIV/AIDS patients.  
• Plans of the federal agencies, states and jurisdictions to qualitatively and quantitatively 
monitor changes in prevention, care and treatment of PLWH as ACA is implemented. 
• Plans of the federal agencies to use federal funding to count toward the Medicaid spend 
down, particularly to increase medication adherence among minority PLWH. 
• Efforts by the federal agencies, states and stakeholder organizations to develop and 
distribute consumer education materials and other resources for PLWH, particularly to 
address the complexities of ACA enrollment in a simplified manner and increase health 
insurance literacy. 
• CMS’s plans to widely distribute lessons learned, experiences and best practices by 
states that intend to amend their state plans and adopt preventive services for new and 
traditional Medicaid populations without cost sharing. 
Public Comment Session 
Ms. Dempsey opened the floor for public comments; no participants responded. 
Preparation for the CHAC Business Session 
Antigone Dempsey MEd, CHAC co-Chair 
Deputy Director, Knowledge, Transfer and Technical Assistance 
HIV/AIDS Lead, Altarum Institute 
Ms. Dempsey reviewed key topics from the presentations and discussions on day 1 of the 
meeting that would be drafted as recommendations or resolutions and presented for CHAC’s 
formal vote during the business session on the following day. 
Topic 1: CDC’s PwP Guidelines 
• Champions: Tommy Chesbro; Antigone Dempsey, MEd; Kali Lindsey 
• Focus: Development of provider-specific questions and integration of SAMHSA’s 
existing assessment tools.  Several CHAC members expressed an interest in rebranding 
“Prevention with Positives” as “Prevention with Persons Living with HIV.” 
Topic 2: Drug Formularies and Health Insurance Plans 
• Champions: Kathleen Clanon, MD; Carlos del Rio, MD; Jennifer Kates, PhD 
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• Focus: Changes to Medicaid coverage for PLWH as a result of ACA, including drug 
formularies and health insurance plans 
Topic 3: The future structure and evolution of RWHAP 
• Champions: Kathleen Clanon, MD; Angelique Croasdale, MA; Dawn Fukuda, ScM; 
Jeanne Marrazzo, MD, MPH 
• Focus: HRSA guidance to RWHAP grantees to further improve short-term continuity of 
care for PLWH; development of specific messaging for RWHAP; and flexibility to allow 
local RWHAP providers to define a set of acceptable Medicaid measures under ACA in 
one visit 
With no further discussion or business brought before CHAC, Ms. Dempsey recessed the virtual 
meeting at 4:02 p.m. on November 13, 2013. 
Opening Session: November 14, 2013 
Laura Cheever, MD, ScM 
Associate Administrator and Chief Medical Officer, HIV/AIDS Bureau 
Health Resources and Services Administration 
CHAC Designated Federal Official, HRSA 
Dr. Cheever conducted a roll call to determine the CHAC voting members, ex-officio members 
and liaison representatives who were attending the virtual meeting.  She announced that CHAC 
meetings are open to the public and all comments made during the proceedings are a matter of 
public record. 
Dr. Cheever reminded the CHAC voting members of their individual responsibility to identify real 
or perceived conflicts of interest and recuse themselves from voting or participating in these 
matters.  None of the voting members publicly disclosed any individual or institutional conflicts 
of interest for the record that were new or different than those declared on day 1 of the meeting. 
Dr. Cheever verified that the voting members and ex-officio members constituted a quorum for 
CHAC to conduct its business on November 14, 2013.  She reconvened the proceedings at 
10:01 a.m. and welcomed the participants to day 2 of the virtual CHAC meeting. 
Antigone Dempsey MEd, CHAC co-Chair 
Deputy Director, Knowledge, Transfer and Technical Assistance 
HIV/AIDS Lead, Altarum Institute 
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Ms. Dempsey also extended her welcome and thanked the participants for ensuring that day 1 
of the first virtual CHAC meeting was productive.  She reviewed the overviews and workgroup 
reports that would be presented on day 2 of the meeting.  Ms. Dempsey concluded her opening 
remarks by summarizing the topics that would be presented for CHAC’s formal vote during the 
business session. 
A panel of HRSA leadership presented a series of overviews describing the ongoing activities of 
various bureaus to meet the primary care workforce needs in the United States, such as the 
implementation of specific strategies and development of interdisciplinary teams.  The purpose 
of the overviews was to describe the landscape and increase understanding of the current HIV 
care and treatment workforce; highlight potential workforce gaps in the future; and discuss the 
possibility of expanding the roles of mid-level providers.  The overviews are outlined below. 
Jennifer Fiedelholtz, MPP 
Director, Office of Policy Coordination 
Bureau of Health Professions 
Health Resources and Services Administration 
Ms. Fiedelholtz described HRSA’s activities to meet the primary care workforce needs in the 
United States.  The key goals for the future workforce are to provide high quality care at a 
reasonable cost; assure access to care; increase diversity to improve health equity; make 
effective use of the current workforce through innovation, training and continuous education; 
and help health workers to fully practice consistent with their education, training, competencies 
and credentials. 
Several major developments and trends impact the health workforce.  Most notably, the demand 
for healthcare services has increased as the U.S. population has grown and aged.  Healthcare 
reform has added insurance coverage for millions of new individuals and also has improved 
coverage for millions of other persons.  Increased costs of healthcare services and healthcare 
technology are unsustainable.  The needs of the healthcare workforce are uncertain.  Issues 
related to inefficiencies and the potential for overuse are problematic.  These developments and 
trends have led to increased interest in identifying strategies to improve efficiency and improve 
health outcomes. 
Panel Presentation: Clinical Workforce Issues and the Affordable Care Act
HRSA currently is focusing on areas that are particularly challenging for the workforce.  
Potential shortages in primary care, chronic/long-term care, behavioral health and oral health 
are specific areas of concern.  The existing workforce is not equitably distributed.  Increased 
workforce diversity is a critical need to assure health equity.  Health workers are not used to the 
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maximum of their education and skills.  The impact of the changing healthcare system on 
individual health occupations needs to be rigorously assessed and analyzed.  The development 
of a comprehensive data system to inform healthcare workforce decisions is a critical need 
across all HRSA bureaus, HHS agencies and states. 
The national healthcare labor supply has dramatically grown from 1950 to 2010 based on data 
showing health employment per 100,000 population.  Most notably, HRSA has allocated a great 
deal of funding to support the rapid growth in three components of the workforce:  physician 
assistants, nurse practitioners and graduate medical education.  However, HRSA is continuing 
to analyze demand versus supply, retirements, distribution and other factors that affect the 
workforce supply. 
The mission of the HRSA Bureau of Health Professions (BHPr) is to increase the nation’s 
access to quality health care, particularly for underserved persons, by developing, distributing 
and retaining a diverse and culturally competent health workforce.  BHPr strongly focuses on 
the primary care workforce to help build the broader healthcare workforce.  The BHPr budget 
decreased from $678 million in FY2012 to $600 million in FY2013.  The FY2014 President’s 
budget request includes a further decrease for BHPr to $461 million.  However, a revolving fund 
supports a loan repayment program for several BHPr grantees. 
BHPr is focusing on healthcare workforce planning through its National Center for Healthcare 
Workforce Analysis.  The core activities of this initiative are highlighted as follows.  Healthcare 
workforce data collection and analysis are being expanded and improved.  BHPr’s datasets, 
including Area Health Resource files, are available on its website. 
BHPr collaborates with states and professional organizations to build a minimum dataset on 
several health professions.  Projections of the workforce supply, demand and need are being 
improved.  BHPr posts reports of its projections on its website, but findings, data and other 
information also are widely disseminated to key stakeholders.  Health workforce planning 
capacity is being strengthened at the state level. 
BHPr primarily funds academic institutions that support training and education across a wide 
array of health professions, including medicine, nursing, public health, geriatrics, physician 
assistants and behavioral health.  The BHPr initiatives that focus on building the workforce 
supply include the ACA-funded Teaching Health Centers (THC) Program to support primary 
care, medical and dentistry residencies in community-based settings. 
Federally Qualified Health Centers (FQHCs) in underserved areas account for the large number 
of THC Program participants.  Research shows that students who train in underserved areas 
are more likely to remain and practice in these communities.  BHPr has more than doubled the 
number of resident full-time equivalents (FTEs) since the inception of the THC Program in 
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FY2010.  BHPr will support >300 primary care resident FTEs in academic year 2013-2014 and 
will graduate the first class of the THC Program in the spring of 2014. 
BHPr has a strong focus on supporting innovations in health professions education and training, 
particularly interprofessional and team-based care.  BHPr and four private foundations began 
supporting the new National Center for Interprofessional Education and Collaborative Practice in 
FY2013 with five-year funding of $16 million.  The primary goals of this initiative are to identify 
best practices and effective models, evaluate outcomes and disseminate information on training 
practitioners in interprofessional education.  To support this effort, BHPr is developing metrics to 
assess the quality of team-based care, such as the impact of interprofessional education on 
reducing healthcare costs and improving health outcomes.  BHPr also supports Title VII and VIII 
programs to promote primary care and community-based training. 
Rene Sterling, PhD, MHA 
Senior Advisor, Office of Quality and Data 
Bureau of Primary Health Care 
Health Resources and Services Administration 
Dr. Sterling described key themes regarding HIV in the primary care workforce.  The HRSA 
Bureau of Primary Health Care (BPHC) has tremendously grown from 2008 to 2012:  a 23.2% 
increase in the number of patients, a 19.4% increase in the number of sites, and a 31.1% 
increase in the number of jobs.  The top three revenue sources of BPHC grantees are Medicaid 
(38%), the BPHC 330 Grant (18%), and state, local or other funding sources (17%). 
Of 21.2 million patients served by FQHCs in 2012, 93% were below 200% of the FPL, 62% 
were racial/ethnic minorities, 36% were uninsured, ~1 million were homeless, 903,089 were 
migrants or seasonal farmworkers, and 219,220 were residents of public housing.  These 
patients made ~94 million visits to FQHCs in 2012.  FQHCs represent 1,198 grantees at >8,900 
service sites.  The FQHC workforce of >148,000 staff includes >10,400 physicians and >7,500 
nurse practitioners, physician assistants and certified nurse-midwives. 
BPHC maintains close collaborations across other HRSA bureaus and HHS agencies to focus 
on three major themes related to HIV in the primary care workforce.  To “build the HIV 
workforce,” BPHC avoids shifting the existing workforce from Ryan White clinics to FQHCs.  
Instead, BPHC is training primary care physicians and other providers in basic health care 
through peer-based learning, clinical consultation and tele-health modalities.  BPHC also trains 
FQHC leadership, boards and staff on the HIV epidemic in their local service areas and other 
relevant issues. 
To “integrate HIV into the current scope of FQHC projects,” BPHC defines and delineates HIV 
primary healthcare services that reasonably could be provided by a primary care physician with 
a source for clinical consultation.  This definition establishes a minimum threshold for FQHCs to 
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reach and eventually expand; informs the development of AETC curricula and other training or 
TA resources for use by FQHCs; and allows for awarding of supplemental funding to FQHCs to 
support HIV activities.  However, supplemental funding cannot be used to expand the current 
scope of FQHC projects.  BPHC also uses HIV integration models for FQHCs to facilitate and 
strengthen new and existing community-based partnerships. 
The primary characteristics and requirements of FQHCs are highlighted as follows.  FQHCs 
must be located in or serve medically underserved areas or populations.  FQHCs must be 
governed by a community-based board with a majority of patients who represent the 
populations served.  FQHCs must provide comprehensive, culturally competent and quality 
primary healthcare and supportive services.  Section 330 of the Public Health Service Act 
delineates the required and additional primary heath services of FQHCs and defines the scope 
of FQHC projects. 
To develop an HIV infrastructure, BPHC places strong emphasis on reengineering and 
revamping FQHCs at a systems level.  The key activities and resources to achieve this goal 
include training of FQHC clinicians, leadership and staff; integration of HIV into existing FQHC 
policies, procedures and protocols; EHRs, clinical decision support for HIV care, and system 
enhancements; PCMH recognition; and care coordination across the healthcare system. 
BPHC’s next steps to advance its focus on HIV in the primary care workforce are to collaborate 
with CDC to build on lessons learned and expand HIV measures in the HRSA Uniform Data 
System (UDS).  BPHC also has identified several new venues and partnerships to develop 
materials and disseminate information:  a listserve to facilitate ongoing communications with all 
FQHC Clinical Medical Officers; circulation of risk alerts and practice alerts through the Federal 
Tort Claims Act Program; and collaboration with national CoAgs that focus on special population 
health. 
Philip Budashewitz, RPh, MA, CAPT USPHS 
Director, Policy and Shortage Designation 
Bureau of Clinician Recruitment and Service, National Health Service Corps 
Health Resources and Services Administration 
Capt. Budashewitz described the role of the National Health Service Corps (NHSC) in 
addressing primary care workforce needs.  NHSC was established in 1972 to expand access to 
health care, address inequitable distributions in providers across the country, and improve the 
health of persons who live in three types of health professional shortage areas (HPSAs):  
clinical/medical care HPSAs, oral/dental health care HPSAs, and behavioral/mental health care 
HPSAs. 
By program, the total NHSC “field strength” includes >40,000 clinicians who have worked in 
underserved communities in the field since the establishment of NHSC in 1972.  By year, the 
 
 
Meeting Minutes: CDC/HRSA Advisory Committee on 
HIV, Viral Hepatitis and STD Prevention and Treatment 
November 13-14, 2013  ♦  Page 26 
 
NHSC field strength has grown from 3,601 clinicians in FY2008 to 8,899 clinicians in FY2013.  
Due to three separate funding sources in FY2011 (e.g., base appropriations, the Recovery Act 
and ACA), the 10,279 funded clinicians accounted for the highest field strength in the history of 
NHSC.  By category, the FY2013 NHSC field strength breaks down as follows:  multiple types of 
mental health providers (27%), physicians (27%), nurse practitioners (16%), dentists (13%), 
physician assistants (13%), dental hygienists (2%), and nurse midwives (2%). 
Of $1.5 billion that ACA will provide to NHSC over the next five years, the HRSA Bureau of 
Clinician Recruitment and Service (BCRS) will award $305 million in contracts for individuals to 
provide direct clinical care in FY2014.  BCRS expects to make 4,513 Student to Service (S2S) 
Loan Repayment Program awards, 211 Scholarship Program awards, and 100 Loan 
Repayment Program (LRP) awards.  The number of funding awards that will be made under the 
State Loan Repayment Program has not been determined at this time. 
Of >5,700 LRP applications that were submitted in FY2013, BCRS made 2,106 new awards.  
Individual awards were up to $60,000 to clinicians placed in HPSAs with scores of >14 and up 
to $40,000 to clinicians placed in HPSAs with scores of <13.  BCRS determines HPSA scores 
based on the shortage of clinicians in the area.  The key features for LRP applicants include an 
electronic employment verification system and credits for the provision of telemedicine services.  
BCRS will conduct the FY2014 LRP application cycle in January-March 2014. 
Of >1,700 Scholarship Program applications that were submitted in FY2013, BCRS made 180 
new awards.  Upon completion of training, scholars are required to provide one year of service 
in NHSC for each year of support provided (or a minimum of 2 years of service).  Scholarship 
Program awards include tax-free payments for tuition and required fees, tax-free payments for 
books and other educational needs, and a taxable monthly living stipend.  The key features for 
Scholarship Program applicants include resources under the “Getting Prepared for NHSC 
Service Program” (e.g., webinars, social media communications, a mentor program and virtual 
job fairs).  BCRS will conduct the FY2014 Scholarship Program application cycle in February-
April 2014. 
Of 100 S2S Program applications that were submitted in FY2013, BCRS made 78 awards.  The 
average debt per application was >$200,000.  The pilot S2S Program is targeted to medical 
students in their fourth year of training who must match their primary care residency to an 
NHSC-designated discipline.  The key features for S2S Program applicants include placement 
assistance and loan repayment of $120,000 for a three-year commitment.  BCRS plans to make 
100 awards after the FY2014 S2S Program application cycle closes on November 14, 2013. 
For all NHSC programs, applicants must be a U.S. citizen or national.  For specific NHSC 
programs, LRP applicants must be licensed in an NHSC-designated discipline.  Scholarship 
Program applicants must be a full-time student at an accredited school or pursuing a degree in 
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an NHSC-designated discipline.  S2S Program applicants must plan on completing an 
accredited primary medical care residency in an NHSC-designated discipline. 
The types of sites that are eligible for NHSC greatly vary:  FQHCs and “Look-Alike” Health 
Centers, American Indian Health Facilities (e.g., Indian Health Service Facilities, Urban Indian 
Health Programs and Tribally-Operated 638 Health Programs), Certified Rural Health Clinics, 
Community Mental Health Centers, state/county health departments, critical access hospitals, 
community outpatient facilities, private practices, free clinics, correctional/detention facilities, 
school-based clinics, and mobile units/clinics.  However, all sites must meet the same set of 
criteria for inclusion in NHSC: 
• Location in a federally-designated HPSA 
• Provision of primary medical, dental or mental/behavioral healthcare services 
• Assurance of access to ancillary, inpatient and specialty referrals 
• Provision of services regardless of the patient’s ability to pay 
• Acceptance of patients covered by Medicare, Medicaid or CHIP 
• No discrimination in the provision of services 
• Provision of a supportive environment and agreement not to reduce a provider’s salary 
due to NHSC support 
• Provision of sound fiscal management 
• Provision of free or reduced-cost services to persons at or below 200% of the FPL 
BCRS launched the redesigned NHSC Jobs Center website in May 2012.  The updated website 
includes Google Maps technology, a “site profile” webpage for sites to describe their success 
stories, and enhanced search features to locate specific sites, vacancies and HPSA scores by 
state or city.  The NHSC Jobs Center website averages >40,400 visits per month.  BCRS also 
has ensured that updated information on NHSC is regularly available through multiple platforms:  
social media (e.g., Facebook, Twitter and YouTube), a HRSA e-mail address and website, and 
a toll-free telephone number. 
 
Sylvia Trent Adams, PhD, RADM USPHS 
Deputy Associate Administrator, HIV/AIDS Bureau 
Health Resources and Services Administration 
Dr. Trent Adams informed CHAC that HAB funding of the “HIV Clinical Workforce Study” was 
initiated in 2010 and ended in the summer of 2013.  Because the final report is undergoing 
HRSA’s internal review process at this time, specific details on the study have not been cleared 
for public discussion.  She expected that the clearance process would be completed over the 
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CHAC discussed the following topics in the question/answer session with leadership of the 
HRSA bureaus on their current activities to meet the primary care workforce needs in the United 
States. 
• The possibility of HRSA repeating its previous HIV workforce consultation with diverse 
groups, particularly to address new issues related to ACA and discuss new findings from 
the upcoming report of the HIV Clinical Workforce Study. 
• The ability of the “Treatment as Prevention” framework to emphasize the importance of 
including HIV treatment in the integrated public health/primary care model. 
• Development of a surveillance system to formally track and monitor specific activities by 
the HIV workforce and the provision of HIV services in each jurisdiction on an ongoing 
basis. 
• The role of HRSA-funded Primary Care Associations in HIV workforce activities at state 
and regional levels. 
• BPHC’s CoAg funds, partnerships and other activities to more fully integrate viral 
hepatitis and sexual health in FQHCs. 
• BPHC’s ongoing efforts to make HIV expansion capacity dollars available to FQHCs that 
do not have PCMH recognition. 
• Establishment of a set of cross-cutting themes or criteria (e.g., data, education or 
creative tele-health experience) as the standard to define a high level of capacity for a 
skilled, qualified and credible primary care workforce. 
• The need to include psychiatrists and behavioral health specialists in interdisciplinary 
teams. 
• Improved training to HIV clinicians on pain management to minimize prescription drug 
abuse of their patients. 
CHAC advised HRSA to apply the “HIV Treatment and Care Cascade” or the “HIV Continuum of 
Care” as a framework to utilize various provider skills, activities and systems to facilitate 
integration across agencies and diseases in a holistic manner.  For example, providers who 
care for persons at risk for HIV (i.e., the pre-infection phase) also could use the same 
opportunity to assess their sexual health risks, drug use and other risk behaviors.  These 
providers could then engage clinicians or specialists to provide expertise on ARVs and other 
specialty issues related to HIV. 
Overview of the HIV Testing Measure for Federally Qualified Health Centers 
Rene Sterling, PhD, MHA 
Senior Advisor, Office of Quality and Data 
Bureau of Primary Health Care 
Health Resources and Services Administration 
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Dr. Sterling presented an overview of the HIV testing performance measure that BPHC is 
proposing to establish for FQHCs and incorporate into UDS.  UDS is a core set of information 
that is appropriate for reviewing the operation and performance of FQHCs.  UDS also serves as 
a reporting system for FQHCs and “Look-Alike” Health Centers (i.e., Health Centers that meet 
all 330 Program requirements, but do not receive 330 Program funding). 
UDS maintains data on both FQHC grantees and Look-Alike Health Centers, including the age, 
race/ethnicity and other characteristics of patients as well as the services, clinical and cost data, 
use of EHRs and PCMH recognition of an individual FQHC.  UDS maps allow users to pinpoint 
the location of FQHCs and identify primary care and sociodemographic-related data.  UDS data 
are publicly available on the BPHC website. 
BPHC added several FQHC-specific performance measures to UDS in 2008, including clinical, 
fiscal, quality of care and disparities measures.  UDS performance measures have shown 
continued growth in HIV testing at FQHCs.  For example, the number of patients FQHCs have 
tested for HIV has increased from 691,208 in 2009 to 999,484 in 2012.  The number of patients 
FQHCs have served with a primary or secondary diagnosis of HIV has increased from 94,972 in 
2009 to 114,881 in 2012. 
BPHC received approval from the Office of Management and Budget (OMB) to adopt 2 of the 7 
HHS core measures.  “Linkage to care” will be reported as an outreach/quality of care measure 
for patients whose first ever HIV diagnosis was made by FQHC staff between October 1 and 
September 30 and who were seen for follow-up within 90 days of the first ever diagnosis.  “HIV 
positivity rate” will be reported as a patient count for persons diagnosed with HIV for the first 
time ever in their lifetime.  FQHCs will begin collecting these data in 2014 and BPHC will report 
its first full year of data from the two HHS core measures in 2015. 
BPHC has participated in numerous calls with stakeholders over the past year to obtain external 
input on clearly defining and establishing an HIV testing performance measure for FQHCs.  
Based on this feedback, BPHC is proposing the following HIV testing measure.  The measure 
would be targeted to patients 15-65 years of age who have ever been tested for HIV in their 
lifetime.  The measure would be aligned with USPSTF recommendations and ongoing activities 
of its federal partners. 
The HHS Office of the National Coordinator for Health Information Technology is funding a one-
year contract to implement an e-Specify HIV screening measure and develop clinical decision 
support.  CDC is making efforts to add an HIV screening measure to Meaningful Use Stage 3 
criteria and the Medicaid Adult Core Measure Set.  After these activities are completed, BPHC 
anticipates submitting its proposed HV testing measure for FQHCs for OMB approval by 2015. 
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CHAC advised BPHC to require FQHCs to track CD4 counts and the time at which persons 
access care.  This measure would be important to improve early diagnosis of HIV, particularly 
for minority populations that typically enter care late with an AIDS diagnosis. 
Update by the CHAC Data Workgroup
 
Jennifer Kates, PhD, CHAC Member 
Vice President & Director, Global Health and HIV Policy 
Kaiser Family Foundation 
Dr. Kates covered the following topics in her update on the workgroup’s recent activities.  CHAC 
unanimously approved the formation of the workgroup with a charge of gathering and analyzing 
CDC and HRSA data to track the impact of ACA on PLWH at implementation and over time. 
The workgroup is utilizing several key sources to fulfill its charge:  CDC Medical Monitoring 
Project data; CDC’s first national estimates of PLWH who are in care and uninsured, but will 
gain new coverage under ACA; and HRSA data on RWHAP clients by insurance and income 
status. 
Update by the CHAC Ryan White Reauthorization Workgroup 
Kathleen Clanon, MD, CHAC Member 
Director, Division of HIV Services 
Alameda County Medical Center 
Dr. Clanon covered the following topics in her update on the workgroup’s recent activities.  The 
RWHAP legislation has expired and has not been rewritten or reauthorized at this time.  The 
workgroup will propose a resolution during the business session for CHAC to extend its charge 
to formulate guidance on the future of RWHAP, particularly its intersection with ACA.  If CHAC 
approves the extension, the workgroup intends to propose recommendations to CDC and HRSA 
in the following areas. 
• Advice to HRSA-funded grantees to comply with RWHAP’s statutory role as the payer of 
last resort 
• Advice to HRSA-funded grantees to help PLWH navigate the enrollment process for 
ACA Exchanges 
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• Advice to HRSA on compiling pharmacy data on single-tablet HIV regimens to make a 
strong argument about state plan formularies 
• Advice to CDC and HRSA on long-term action steps or specific information the agencies 
should provide over the next 4-5 years 
Update by the CHAC Integration Workgroup
Bruce Agins, MD, MPH, CHAC Member 
Medical Director, AIDS Institute 
New York State Department of Health 
William Garrett 
Program Associate, AIDS Institute 
New York State Department of Health 
Kali Lindsey, CHAC Member 
Director, Government Affairs and Communications 
National Minority AIDS Council 
The workgroup covered the following topics in the update on its recent activities.  Since its 
formal establishment during June 2013 CHAC meeting, the workgroup has reviewed existing 
integration models, analyses and taxonomy to refine its charge and better understand the 
complexities related to integration.  The workgroup focused on answering four key questions in 
this effort. 
One, what services should be included in integration?  Different infectious diseases (e.g., 
hepatitis, STDs and TB) should be integrated into HIV care.  These infectious diseases also 
should be integrated into primary care and the public health/primary care model, particularly the 
integration of HIV/HCV/STD prevention and care into CHCs; the integration of HIV/HCVSTD 
care into general medical care; and the integration of hospital HIV clinics into the larger 
healthcare system. 
In terms of subpopulations, HIV/HCV/STD should be integrated into a population-specific 
framework, such as expanded LGBT, mental health and substance abuse programs and the 
integration of behavioral health into HIV care.  Experiences and lessons learned from other 
models should be considered, such as the provision of family-centered care through the 
integration of maternal and child HIV care and Chronic Disease Centers or models that integrate 
care for chronic disease patients (e.g., the integration of HIV into diabetes or heart disease).  To 
assist in answering question 1, the workgroup reviewed a briefing document that the National 
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Alliance of State and Territorial AIDS Directors (NASTAD) recently released on the status of 
collaboration between CHCs and health departments. 
Two, is full integration needed for integrated service delivery models?  To assist in answering 
question 2, the workgroup reviewed the 2010 Shigayeva, et al. paper, “Health Systems, 
Communicable Diseases and Integration.”  The study reported that the levels of integration 
include no formal interaction between programs, partial integration through linkage or 
coordination, and full integration.  The workgroup presented the Shigayeva paper with detailed 
definitions on each type of integration model for CHAC’s review. 
Three, what are the specific components of a full integration model?  The workgroup’s literature 
review showed that several areas of a program would need to be integrated in order to achieve 
full integration:  service delivery, governance, financing/funding systems, strategic planning, 
leadership support and endorsement, and quality measures to demonstrate impact. 
Four, what experiences and lessons learned can be applied from existing integration models?  
The workgroup identified several examples of integration in its literature review:  Department of 
Veterans Affairs healthcare facilities, Project ECHO® (Extension for Community Healthcare 
Outcomes), CDC’s Program Collaboration and Service Integration demonstration projects, and 
services for subpopulations (e.g., LGBT, mental health and substance abuse programs). 
CHAC made several suggestions in response to the workgroup’s request for input on its next 
steps, areas of focus and future directions.  
• Integrate viral hepatitis into behavioral health care and maternal/child health care. 
• Integrate family planning or women’s health care into HIV care. 
• Address the tension between service integration and policies and the integration of 
different infectious disease programs along the point of service. 
• Specifically name “Opioid Treatment Centers” in programs that integrate substance 
abuse and HIV/HCV/STD care. 
• Focus on specific policies, federal agencies, barriers and national strategies/measures 
(e.g., NHAS) that will impact services included in integration. 
• Identify opportunities for integration in ACA (e.g., the shift to EHRs and best practices 
from the CMMI-funded Health Care Innovation Awards). 
• Use the new White House Executive Order on continuum of care as an opportunity to 
emphasize the importance of integration in reaching persons across the spectrum of 
their needs and improving all health outcomes. 
• Formulate guidance on integration from an individual patient/client perspective rather 
than from a broad systems level.  An ideal integration model would provide linkages to 
care, treatment and other services for persons with a new positive HIV test and also 
would provide referrals to relevant services for persons with a new negative HIV test to 
maintain their status.  For example, a Ryan White medical home provides patients with 
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medical and psychiatric care, various testing, and linkages to treatment for abuse of 
opioids or other substances. 
Dr. Agins thanked CHAC for its concrete suggestions on the workgroup’s next steps, areas of 
focus and future directions.  However, he emphasized that the workgroup would need outside 
expertise on ACA and other issues to respond to some of CHAC’s suggestions. 
CHAC Business Session 
Topic 1: Adoption of the Draft CHAC Meeting Minutes 
Antigone Dempsey MEd, CHAC co-Chair 
Deputy Director, Knowledge, Transfer and Technical Assistance 
HIV/AIDS Lead, Altarum Institute 
Jeanne Marrazzo, MD, MPH, CHAC co-Chair 
Professor of Medicine, Harborview Medical Center 
University of Washington 
Ms. Dempsey and Dr. Marrazzo opened the business session and called for CHAC’s review, 
discussion and/or formal action on the following topics. 
 
Ms. Dempsey entertained a motion for CHAC to approve the previous meeting minutes.  A 
motion was properly placed on the floor and seconded by Mr. Kali Lindsey and Mr. Guillermo 
Chacon, respectively, for CHAC to approve the previous meeting minutes. 
 
CHAC unanimously adopted the Draft June 18-19, 2013 Meeting Minutes with no changes 
or further discussion. 
 
Topic 2:  Prevention with Persons Living with HIV (formerly “Prevention with Positives”) 
Champions: Tommy Chesbro; Antigone Dempsey, MEd; Kali Lindsey
 
The following motion was properly placed on the floor and seconded by Mr. Guillermo Chacon 
and Dr. Virginia Caine, respectively. 
 
Given the important impact that both early engagement with a healthcare provider and 
initiation of treatment above 500 establish optimal health and prevention outcomes for 
persons living with HIV (PLWH), strategies and interventions to support sustained viral 
suppression have primacy in addition to primary prevention efforts for opportunistic 
infections and other STDs, such as hepatitis and syphilis. 
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• CHAC recommends that CDC collaborate with HRSA to bring its Prevention with 
Persons Living with HIV (PwPLWH) Guidelines to completion and online.  CHAC 
expects that the completed guidelines will be presented at the next meeting in May 
2014. 
• CHAC recommends that the PwPLWH Guidelines include input from providers and 
PLWH.  Modules addressing brief screenings for addictions and mental health 
issues, intimate partner violence, and strategies to mitigate behaviors that may be 
adopted to manage certain life circumstances should be included as well. 
• CHAC recommends that CDC and HRSA assess the viability of a user tool for 
providers either through electronic medical records or a downloadable application. 
CHAC proposed the following amendment to the motion: 
• Include new language describing strategies to reduce stigma among PLWH. 
CHAC unanimously approved the resolution with the proposed amendment. 
Topic 3:  Drug Formularies and the Healthcare Exchange 
Champions: Kathleen Clanon, MD; Carlos del Rio, MD; Jennifer Kates, PhD 
The following motion was properly placed on the floor and seconded by Drs. Bruce Agins and 
Jeanne Marrazzo, respectively. 
CHAC notes that as more persons living with HIV gain access to private insurance 
coverage through new Healthcare Marketplaces being established in each state, access 
to recommended antiretroviral (ARV) therapy also should be available as specified in 
HHS guidelines.  The final HHS rule for coverage of prescription drugs in the 
marketplace states that plans must cover “at least the greater of 1 drug from every U.S. 
Pharmacopeia category and class or the same number of prescription drugs in each 
category and class as the EHB benchmark.”  However, the final HHS rule does require 
plans to have procedures in place to “allow an enrollee to request and gain access to 
clinically appropriate drugs not covered by the health plan.” 
Because of this, concerns have been raised and early data support the following.  (1) 
Not all recommended combination antiretroviral therapeutic regimens are covered by all 
plans in each Marketplace.  (2) Several state qualified health plans are placing all HIV 
antiretrovirals on the highest cost-sharing tier and requiring prior authorization for these 
medications.  (3) Obtaining data on plan coverage of ARVs by state is difficult and poses 
considerable challenges to Ryan White grantees, particularly AIDS Drug Assistance 
Programs that need this information to assess their ability to help clients purchase plan 
coverage in the Marketplace.  (5) No clear guidance has been given to plans about the 
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HHS HIV Treatment Guidelines.  (6) Plan processes for allowing enrollees to request 
access to clinically appropriate drugs not covered by a plan are not yet available or easy 
to obtain. 
Therefore, CHAC requests that HRSA work with its federal partners, particularly the 
HHS Center for Consumer Information and Insurance Oversight, to: 
1. Assess the extent of ARV coverage by plan in each Marketplace and ensure that 
formulary and cost information are readily available; 
2. Provide guidance to plans regarding discriminatory formulary designs that include, as 
an example, placing all HIV medications in the highest cost-sharing tier; 
3. Conduct specific outreach to state Marketplaces where plans do not cover 
recommended combination therapies; and 
4. Ensure that policies allowing enrollees to request access to clinically appropriate 
drugs not covered by plans be accessible and readily available. 
CHAC proposed the following amendments to the motion: 
• Include new language to ensure that problems with formularies and the Healthcare 
Exchange do not interfere with the ability to achieve optimal patient outcomes and 
impact the quality of care. 
• Specifically name the single-tablet regimens in item 3. 
• Acknowledge the ongoing efforts by HIV Medicine Association, NASTAD and other 
organizations in this recommendation. 
CHAC unanimously approved the resolution with the proposed amendments. 
Topic 4:  Changes to the Ryan White HIV/AIDS Program (RWHAP) 
Champions: Kathleen Clanon, MD; Angelique Croasdale, MA; Dawn Fukuda, ScM; 
Jeanne Marrazzo, MD, MPH 
It appears that the RWHAP authorizing law will not be rewritten in the near future.  
CHAC notes the complex interactions between ACA provisions and the current RWHAP 
language.  In particular, the Payer of Last Resort provision and 75/25 rule in RWHAP 
may have unintended consequences in the era of health reform, serve to reduce the 
comprehensiveness of HIV care provided by RWHAP, and have consequences for both 
individual and public health outcomes.  CHAC strongly [advises? directs?] HRSA and its 
partners to review program guidance, particularly for RWHAP Parts A, B, C, and D, to 
explore updating the definitions of care to recognize the following: 
• Allowable services under the medical services program may include primary care of 
PLWH, specialty HIV care, or adherence/risk reduction visits.  Each of these services 
can be provided by a medical team under the direction of a physician and a given 
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care episode may include one or more of these visit types.  However, there may be 
widely varying levels of reimbursement for these services and requirements for 
licensure or certification for providers who deliver them.  Given the uncertainty of 
coverage scopes under both expanded public and private insurance options 
available through ACA, CHAC recommends that HRSA develop a staged analysis 
during implementation of healthcare reform at the jurisdictional level and perform a 
corresponding assessment of policies related to payer of last resort requirements. 
• All PLWH do not need the same interventions to be successful with treatment, yet 
RWHAP assumes that.  CHAC recommends that HRSA review RWHAP guidance to 
allow for a service package that is based on presenting health status, acuity level, 
and other psychosocial and environmental considerations and is measured by goals 
jointly established by the consumer and medical care team, including sustained viral 
suppression, optimal visits and laboratory frequency.  This approach would allow for 
RWHAP clients to be triaged by patient level of need and at varying levels of 
intensity. 
• HRSA should explore strategies to use RWHAP funds to leverage ACA to strengthen 
the Continuum of Care, both in the short- and long-term. 
CHAC endorsed the “general spirit” of the resolution with no formal vote. 
The Ryan White Reauthorization Workgroup would revise the resolution with clearer language 
and more specific recommendations for CHAC’s formal vote by the next meeting. 
Topic 5: Future Agenda Items 
CHAC proposed several topics to include on future meeting agendas. 
• CDC, HRSA Bureaus and CHAC:  Continuation of the workforce agenda item. 
o Overviews by CDC and HRSA grantees on their current activities to strengthen 
workforce capacity by providing more integrated care related to HIV, sexual health, 
viral hepatitis and TB, particularly to ensure concurrence across all of these disease 
categories for vulnerable populations and also to take advantage of tremendous 
advancements in viral hepatitis care.  The overviews should describe integration 
efforts by the CDC and HRSA grantees to overcome problems related to silos and 
resolve barriers to categorical funding that focuses on specific diseases.  The 
following grantees should be invited to present overviews:  CDC-funded Prevention 
Training Centers, HRSA-funded AETCs, HRSA-funded THC Program grantees, and 
HRSA-funded Nurse Education, Practice, Quality and Retention Program grantees. 
o CHAC’s development of formal workforce recommendations to CDC and HRSA in 
the following areas:  maintaining a skilled workforce, addressing LGBT health, and 
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increasing training to HIV providers on pain management to minimize opioid abuse 
among their patients. 
o CHAC’s targeted discussion to identify and fill gaps in three specific areas of 
workforce capacity:  (1) clinicians providing medical care for PLWH; (2) CHCs, safety 
net hospitals and other providers serving vulnerable populations at risk for HIV and 
viral hepatitis; and (3) CHCs serving as true HIV health homes for PLWH based on 
the traditional RWHAP model. 
• HRSA:  Update on the integration of HIV health homes and HIV groups that are 
expanding to include primary care. 
• HRSA: Regular updates on the number of patients FQHCs test for HIV each year 
(numerator) relative to their annual patient populations (denominator). 
• HRSA/AETCs: Presentation with geomapping data that target locations of HIV providers 
who would be willing to mentor primary care providers in rural and underserved areas. 
• CDC: Update on the DASH portfolio, including targeted programming for young gay/ 
bisexual men and expanded access to Early Intervention Services in school health. 
• CDC: Update on the PwPLWH Guidelines in an ACA environment.  The update should 
cover the national emphasis on universal treatment regardless of CD4 count or viral 
load. 
• CDC/HRSA:  Potential strategies to blend prevention and treatment funding streams to 
improve the continuum of care for HIV and HCV.  The presentation should include an 
overview of the IOM analysis regarding the integration of CDC, HRSA, CMS and 
SAMHSA funding streams. 
• Guest Speaker: Overview by the HRSA-funded National LGBT Health Education Center 
at Fenway Institute on its efforts to evaluate health issues and clinical concerns among 
the LGBT community beyond HIV, STDs and other traditional program areas at the 
federal level.  The overview should describe skill sets that are needed to adequately 
assess LGBT sexual behavior, sexual identity and sexual orientation in the context of 
poor health outcomes (e.g., disclosure and increased risk taking).  The overview should 
serve as CHAC’s initial discussion on early diagnoses, biomedical/behavioral prevention 
and interventions for transgender health, particularly to address underlying factors for 
the tremendous disparity in HIV and STD rates among female-to-male transgenders. 
• Guest Speakers:  Panel presentation by RWHAP grantees and other groups that have 
successfully expanded to primary care.  An invitation should be extended to Mike 
Gifford, President and Chief Executive Officer of AIDS Resource Center of Wisconsin, to 
describe experiences and lessons learned in successfully certifiying this organization as 
an HIV medical home through the state Medicaid program. 
Topic 6: Action Items 
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• Ms. Kaye Hayes, CHAC ex-officio member for HHS, will provide CHAC with the website 
link to the minutes of the September 2013 PACHA meeting after the document has been 
cleared for release. 
• Ms. Melissa Harris, of CMS, will provide CHAC with lessons learned, experiences and 
best practices by states that intend to amend their state plans and adopt preventive 
services for new and traditional Medicaid populations without cost sharing. 
• The CDC and HRSA Committee Management Specialists will distribute the IOM analysis 
to CHAC in preparation of the presentation on integrating CDC, HRSA, CMS and 
SAMHSA funding streams. 
• Dr. Hazel Dean, Deputy Director of NCHHSTP, will share lessons that the CDC Advisory 
Council on Tuberculosis Elimination has learned over the past year in convening virtual 
meetings. 
• Dr. Rene Sterling, Senior Advisor to the BPHC Office of Quality and Data, will identify a 
staff member to serve on the CHAC Integration Workgroup on an ongoing basis. 
• The Co-Chairs will draft a letter to provide feedback to the CDC Director, HRSA 
Administrator and HHS Secretary on outcomes of CHAC’s first virtual meeting.  The 
CHAC members should e-mail any points or issues that should be emphasized in the 
letter.  An e-mail will be distributed to assist CHAC in providing qualitative input in 
response to specific questions.  Several CHAC members made comments in the interim: 
o Notification of CHAC’s virtual meeting through a Federal Register notice and the 
HRSA/HAB listserve was not sufficient for public outreach. 
o The virtual meeting was far too compact for three 2.5-hour sessions over two days.  
The number of presentations should be reduced or an additional 2.5-hour session 
should be included on day 2. Most notably, the numerous presentations on ACA 
were difficult to digest and did not allow for extensive discussion by CHAC. 
o Efforts should be made to reinstate CHAC’s two in-person meetings per year.  The 
virtual meeting was helpful, but was not the ideal format for CHAC’s discussions on 
complex issues.  To support this request, CDC agreed to perform a cost analysis to 
compare the differences in labor and other costs between an in-person and virtual 
CHAC meeting. 
The co-Chairs, DFOs and CDC/HRSA leadership thanked the CHAC members and all of the 
attendees for their ongoing participation and extensive engagement over the course of the first 
virtual meeting.  The participants applauded Ms. Shelley Gordon, the CHAC Committee 
Management Specialist for HRSA, for her outstanding efforts in preparing for and overseeing 
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Ms. Dempsey reiterated that the CHAC members would receive e-mail messages soliciting their 
comments and feedback on successes, flaws and areas of improvement related to the first 
CHAC virtual meeting.  She emphasized that this input would serve as the basis in refining 
CHAC’s virtual meetings in the future. 
The next in-person CHAC meeting would be held on May 21-22, 2014 in Atlanta, Georgia.  With 
no further discussion or business brought before CHAC, Ms. Dempsey adjourned the virtual 
meeting at 12:33 p.m. on November 14, 2013. 
       I hereby certify that to the best of my 
knowledge, the foregoing Minutes of the 
proceedings are accurate and complete. 
___________________    ___________________________________ 
Date       Antigone Dempsey, MEd, Co-Chair 
       CDC/HRSA Advisory Committee on HIV, 
       Viral Hepatitis and STD Prevention and 
       Treatment 
___________________    ___________________________________ 
Date       Jeanne Marrazzo, MD, MPH, Co-Chair 
       CDC/HRSA Advisory Committee on HIV, 
       Viral Hepatitis and STD Prevention and 
       Treatment 
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AIDS Directors 
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AIDS Directors 
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AIDS Directors 
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HIV Medicine Association 
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Glossary of Acronyms 
ACA Affordable Care Act 
ADAP AIDS Drug Assistance Program 
AETCs AIDS Education and Training Centers 
ARV Antiretroviral 
BCRS Bureau of Clinician Recruitment and Service 
BHPr Bureau of Health Professions 
BPHC Bureau of Primary Health Care 
CACO Certified Application Counselor Organization 
CBA Capacity Building Assistance 
CBOs Community-Based Organizations 
CDC Centers for Disease Control and Prevention 
CHAC CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment 
CHCs Community Health Centers 
CHIP Children’s Health Insurance Program 
CHNAs Community Health Needs Assessments 
CMMI Center for Medicare and Medicaid Innovation 
CMS Centers for Medicare and Medicaid Services 
CoAg Cooperative Agreement 
DASH Division of Adolescent and School Health  
DFO Designated Federal Official 
DHAP Division of HIV/AIDS Prevention  
DSTDP Division of STD Prevention 
DVH Division of Viral Hepatitis 
EHBs Essential Health Benefits 
EHRs Electronic Health Records 
FOA Funding Opportunity Announcement 
FPL Federal Poverty Level 
FQHCs Federally Qualified Health Centers 
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HAB HIV/AIDS Bureau 
HAV Hepatitis A Virus 
HCV Hepatitis C Virus  
HHS U.S. Department of Health and Human Services 
HPSAs Health Professional Shortage Areas 
HPV Human Papillomavirus 
HRSA Health Resources and Services Administration 
IOM Institute of Medicine 
IRS Internal Revenue Service 
LGBT Lesbian/Gay/Bisexual/Transgender 
LRP Loan Repayment Program 
MSM Men Who Have Sex With Men  
NASTAD National Alliance of State and Territorial AIDS Directors 
NCHHSTP National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention  
NHAS National HIV/AIDS Strategy 
NHSC National Health Service Corps 
NIH National Institutes of Health 
OMB Office of Management and Budget 
PACHA Presidential Advisory Council on HIV/AIDS 
PCMHs Patient-Centered Medical Homes 
PLWH Persons Living with HIV 
PrEP Pre-Exposure Prophylaxis 
PwP; PwPLWH Prevention with Positives; Prevention with Persons Living with HIV 
RFR Rapid Feedback Report 
RWHAP Ryan White HIV/AIDS Program 
S2S Student to Service 
SAMHSA Substance Abuse and Mental Health Service Administration  
SPNS Special Projects of National Significance  
TA Technical Assistance 
TB Tuberculosis 
THC Teaching Health Centers 
UDS Uniform Data System 
USPSTF U.S. Preventive Services Task Force 
 
